Justin Vigar is a synthetic biologist and entrepreneur building next-generation technologies for macrocyclic peptide drug discovery. He co-founded Onca Bio to apply these technologies to high-impact areas, including targeted cancer therapies, delivery technologies, and orally bioavailable peptides.

Justin completed his PhD at the University of Toronto, where he focused on translating foundational advances in synthetic biology into diagnostics and therapeutics. He has served as a delegate and speaker at the UN Convention on Biological Diversity and was selected as a Next Generation Leader at the Asilomar Conference on the Future of Biotechnology.